A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Immuno-Oncology Medicines: Policy Implications and Economic Considerations
2019
INNOVATIONS in Pharmacy
Significant progress has taken place in the field of cancer immunotherapy in recent years. Cancer immunotherapy, particularly immune checkpoint inhibitors, have shown rather dramatic results and are believed to have completely transformed the field of oncology. However, these transformational therapies are more expensive than previous cancer therapies. As more cancer immunotherapy agents are being developed, with some already being marketed, it is important to consider how economic constraints
doi:10.24926/iip.v10i3.1799
pmid:34007565
pmcid:PMC8127089
fatcat:c6p5ghrdmrfwxcf2giot3udmge